Nuvo Pharmaceuticals Inc. announced that its board of directors has appointed Jesse Ledger to the position of President effective immediately. Mr. Ledger was previously Nuvo's Vice-President of Business Development. In his new role, Mr. Ledger will assume additional operational responsibilities and lead the company's initiative to diversify its revenue streams by out-licensing global rights for its lead product. John London, who was previously Nuvo's President and Chief Executive Officer will continue to lead the company as its CEO. Mr. Ledger joined Nuvo in April 2016 as its Vice-President of Business Development. Prior to joining Nuvo, he was Vice-President, Business Development and International Business of Tribute Pharmaceuticals Canada Inc.